Tokai pockets $97M in IPO cash to get its cancer drug into Phase III This biotech has a three-in-one prostate cancer treatment that's been fast tracked by the FDA.
Recruiter contacted me today about their Oncology expansion. Not sure about them Ps, it's Taiho Oncology, a division of Otsuka.